They found that Ki-67 expression was upregulated in the transforming growth factor-β1 (TGF-β1) treated tumors, and TGF-β1 promotes EMT (epithelial-to-mesenchymal transition), migration, and invasion in bladder cancer cells [57]. This evidence concerns the gene MKI67 and urinary bladder cancer.